Editorial & Opinion
أعرض في EDS

Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCD.

التفاصيل البيبلوغرافية
العنوان: Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCD.
المؤلفون: Romano M; Division of Paediatric Rheumatology, Department of Paediatrics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada. micol.romano@lhsc.on.ca., Geerlink A; Division Hematology and Oncology, Children's Hospital at London Health Sciences Centre, Western University, London, ON, Canada., Demirkaya E; Division of Paediatric Rheumatology, Department of Paediatrics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada., Berard RA; Division of Paediatric Rheumatology, Department of Paediatrics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada., Garcia-Bournissen F; Division of Pediatric Clinical Pharmacology, Department of Pediatrics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada.
المصدر: Journal of clinical immunology [J Clin Immunol] 2024 Mar 08; Vol. 44 (3), pp. 78. Date of Electronic Publication: 2024 Mar 08.
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Springer
Original Publication: New York : Plenum, c1981-
مواضيع طبية MeSH: Autoimmune Diseases* , Azetidines*/therapeutic use , Immunologic Deficiency Syndromes* , Osteochondrodysplasias* , Purines* , Pyrazoles*, Humans ; Sulfonamides
References: Frémond ML, Hully M, Fournier B, Barrois R, Lévy R, Aubart M, et al. JAK inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study. J Clin Immunol. 2023;43(6):1436–47. (PMID: 10.1007/s10875-023-01500-z3717174210175907)
Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022;81(5):601–13. (PMID: 10.1136/annrheumdis-2021-22181435086813)
Briggs TA, Rice GI, Adib N, Ades L, Barete S, Baskar K, et al. Spondyloenchondrodysplasia due to mutations in ACP5: a Comprehensive Survey. J Clin Immunol. 2016;36(3):220–34. (PMID: 10.1007/s10875-016-0252-y269514904792361)
Vanderver A, Adang L, Gavazzi F, McDonald K, Helman G, Frank DB, et al. Janus Kinase Inhibition in the Aicardi-Goutières Syndrome. N Engl J Med. 2020;383(10):986–9. (PMID: 10.1056/NEJMc2001362328775907495410)
Kim H, Brooks KM, Tang CC, Wakim P, Blake M, Brooks SR, et al. Pharmacokinetics, Pharmacodynamics, and proposed dosing of the oral JAK1 and JAK2 inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI patients. Clin Pharmacol Ther. 2018;104(2):364–73. (PMID: 10.1002/cpt.93629134648)
An J, Briggs TA, Dumax-Vorzet A, Alarcón-Riquelme ME, Belot A, Beresford M, et al. Tartrate-resistant Acid Phosphatase Deficiency in the predisposition to systemic Lupus Erythematosus. Arthritis Rheumatol. 2017;69(1):131–42. (PMID: 10.1002/art.3981027390188)
المشرفين على المادة: ISP4442I3Y (baricitinib)
0 (Azetidines)
0 (Sulfonamides)
0 (Purines)
0 (Pyrazoles)
SCR Disease Name: Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia
تواريخ الأحداث: Date Created: 20240308 Date Completed: 20240311 Latest Revision: 20240423
رمز التحديث: 20240423
DOI: 10.1007/s10875-024-01680-2
PMID: 38457012
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-2592
DOI:10.1007/s10875-024-01680-2